By Stanford Erickson Two women were, for me, like celebratory bookends to The Myositis Association’s International Annual Patient Conference in Baltimore September 6-8, 2024. One was the opening Friday night…
Continue Reading
TMA’s Women of Color raise the bar for advocacy and support
Kaniah Gunter and Holly Jones
Continue Reading
Announcing the Marianne Moyer Myositis Leader Award
The Myositis Association (TMA) is proud to announce the inaugural Marianne Moyer Myositis Leader Award to be presented at the 2024 Heroes in the Fight Awards Celebration on September 7…
Continue Reading
CAR T-cell therapy: A viable option for myositis treatment?
Chimeric antigen receptor T-cell (CAR T-cell) therapy is a process developed to treat certain forms of cancers, especially blood cancers like leukemia and lymphoma. Recently, however, researchers have started exploring…
Continue Reading
Last call for comments for DM PFDD
TMA was honored to partner with Myositis Support and Understanding (MSU) to host the Externally Led Patient Focused Drug Development (PFDD) meeting for adult dermatomyositis (DM) on June 7. View…
Continue Reading